RBC Europe’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | $15K | Hold |
1,981
| – | – | ﹤0.01% | 459 |
|
|
2022
Q1 | $19K | Hold |
1,981
| – | – | ﹤0.01% | 464 |
|
|
2021
Q4 | $16K | Sell |
1,981
-3,571
| -64% | -$28.8K | ﹤0.01% | 481 |
|
|
2021
Q3 | $54.1K | Hold |
5,552
| – | – | ﹤0.01% | 554 |
|
|
2021
Q2 | $55K | Sell |
5,552
-11,912
| -68% | -$118K | ﹤0.01% | 570 |
|
|
2021
Q1 | $202K | Hold |
17,464
| – | – | 0.01% | 295 |
|
|
2020
Q4 | $169K | Hold |
17,464
| – | – | 0.01% | 310 |
|
|
2020
Q3 | $157K | Sell |
17,464
-7,864
| -31% | -$70.9K | 0.01% | 289 |
|
|
2020
Q2 | $312K | Buy |
25,328
+975
| +4% | +$12K | 0.02% | 196 |
|
|
2020
Q1 | $219K | Hold |
24,353
| – | – | 0.02% | 200 |
|
|
2019
Q4 | $239K | Buy |
24,353
+373
| +2% | +$3.66K | 0.02% | 229 |
|
|
2019
Q3 | $165K | Buy |
23,980
+869
| +4% | +$5.98K | 0.02% | 263 |
|
|
2019
Q2 | $213K | Sell |
23,111
-350
| -1% | -$3.23K | 0.02% | 244 |
|
|
2019
Q1 | $368K | Sell |
23,461
-327
| -1% | -$5.13K | 0.04% | 177 |
|
|
2018
Q4 | $367K | Sell |
23,788
-400
| -2% | -$6.17K | 0.05% | 158 |
|
|
2018
Q3 | $521K | Buy |
24,188
+432
| +2% | +$9.31K | 0.06% | 154 |
|
|
2018
Q2 | $578K | Hold |
23,756
| – | – | 0.07% | 144 |
|
|
2018
Q1 | $406K | Sell |
23,756
-5,898
| -20% | -$101K | 0.05% | 170 |
|
|
2017
Q4 | $562K | Buy |
29,654
+5,000
| +20% | +$94.8K | 0.07% | 147 |
|
|
2017
Q3 | $434K | Buy |
+24,654
| New | +$434K | 0.06% | 164 |
|